` Comparison: ABLI vs AMGN - Alpha Spread

ABLI
vs
AMGN

Over the past 12 months, ABLI has underperformed AMGN, delivering a return of 0% compared to the AMGN's +11% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
ABLI
AMGN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

ABLI Intrinsic Value
HIDDEN
Show
AMGN Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Abliva AB
STO:ABLI
0.444 SEK
Amgen Inc
NASDAQ:AMGN
349.92 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
ABLI, AMGN

ABLI
AMGN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Abliva AB
Revenue
Amgen Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
ABLI, AMGN

ABLI
AMGN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Abliva AB
STO:ABLI
Amgen Inc
NASDAQ:AMGN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

ABLI
0%
AMGN
82.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Abliva AB
Amgen Inc

Operating Margin

ABLI
0%
AMGN
44.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Abliva AB
Amgen Inc

Net Margin

ABLI
0%
AMGN
21%
LTM 3Y Avg 5Y Avg 10Y Avg
Abliva AB
Amgen Inc

FCF Margin

ABLI
0%
AMGN
22%
LTM 3Y Avg 5Y Avg 10Y Avg
Abliva AB
Amgen Inc

ROE

ABLI
-135.9%
AMGN
106.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Abliva AB
Amgen Inc

ROA

ABLI
-111.7%
AMGN
8.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Abliva AB
Amgen Inc

ROIC

ABLI
-313.7%
AMGN
20.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Abliva AB
Amgen Inc

ROCE

ABLI
-137%
AMGN
24.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Abliva AB
Amgen Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
ABLI, AMGN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ABLI, AMGN

Performance Gap Between ABLI and AMGN
HIDDEN
Show

Performance By Year
ABLI, AMGN

Loading
ABLI
AMGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare ABLI to other stocks
PNEXF
Pharnext SCA
More expensive
vs ABLI
ABBV
Abbvie Inc
Cheaper
vs ABLI
GILD
Gilead Sciences Inc
Cheaper
vs ABLI
VRTX
Vertex Pharmaceuticals Inc
Cheaper
vs ABLI
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett